Cargando…

Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges

Neurodegenerative diseases constitute a group of pathologies whose etiology remains unknown in many cases, and there are no treatments that stop the progression of such diseases. Moreover, the existence of the blood–brain barrier is an impediment to the penetration of exogenous molecules, including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cano, Amanda, Muñoz-Morales, Álvaro, Sánchez-López, Elena, Ettcheto, Miren, Souto, Eliana B., Camins, Antonio, Boada, Mercè, Ruíz, Agustín
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863585/ https://www.ncbi.nlm.nih.gov/pubmed/36678926 http://dx.doi.org/10.3390/pharmaceutics15010298

Ejemplares similares

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
por: Cano, Amanda, et al.
Publicado: (2021)

Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways
por: Cano, Amanda, et al.
Publicado: (2021)

Extracellular vesicles, the emerging mirrors of brain physiopathology
por: Cano, Amanda, et al.
Publicado: (2023)

Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges
por: Bonilla, Lorena, et al.
Publicado: (2021)

Current Applications of Nanoemulsions in Cancer Therapeutics
por: Sánchez-López, Elena, et al.
Publicado: (2019)

Lipid Nanoparticles for the Posterior Eye Segment
por: Bonilla, Lorena, et al.
Publicado: (2021)

State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections
por: Cano, Amanda, et al.
Publicado: (2020)

Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
por: Souto, Eliana B., et al.
Publicado: (2019)

Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
por: Ettcheto, Miren, et al.
Publicado: (2019)

State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks
por: García-Torra, Victor, et al.
Publicado: (2021)

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
por: Sánchez-López, Elena, et al.
Publicado: (2018)

Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study
por: Sánchez-López, Elena, et al.
Publicado: (2020)

Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
por: Cano, Amanda, et al.
Publicado: (2019)

Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease
por: Rabieipoor, Saghar, et al.
Publicado: (2023)

Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
por: Poor, Saghar Rabiei, et al.
Publicado: (2021)

Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation
por: Galindo, Ruth, et al.
Publicado: (2022)

Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
por: Sánchez-López, Elena, et al.
Publicado: (2020)

Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
por: Olloquequi, Jordi, et al.
Publicado: (2023)

Artificial exosomes for translational nanomedicine
por: Li, Yong-Jiang, et al.
Publicado: (2021)

Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
por: Folch, Jaume, et al.
Publicado: (2018)

A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2023)

Experimental Models for Aging and their Potential for Novel Drug Discovery
por: Folch, Jaume, et al.
Publicado: (2018)

Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
por: Ettcheto, Miren, et al.
Publicado: (2017)

Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases
por: Jagaran, Keelan, et al.
Publicado: (2021)

Current Research Therapeutic Strategies for Alzheimer's Disease Treatment
por: Folch, Jaume, et al.
Publicado: (2016)

Nanomedicines for the Delivery of Antimicrobial Peptides (AMPs)
por: Teixeira, Maria C., et al.
Publicado: (2020)

Regenerative nanomedicine: current perspectives and future directions
por: Chaudhury, Koel, et al.
Publicado: (2014)

Perspective Insights of Exosomes in Neurodegenerative Diseases: A Critical Appraisal
por: Jan, Arif Tasleem, et al.
Publicado: (2017)

Exosome: A New Player in Translational Nanomedicine
por: Aheget, Houssam, et al.
Publicado: (2020)

Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
por: Ettcheto, Miren, et al.
Publicado: (2021)

Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2022)

Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment
por: Cano, Amanda, et al.
Publicado: (2023)

The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
por: Folch, Jaume, et al.
Publicado: (2019)

Exosomes in Gliomas: Biogenesis, Isolation, and Preliminary Applications in Nanomedicine
por: Romano, Eugenia, et al.
Publicado: (2020)

Tango of dual nanoparticles: Interplays between exosomes and nanomedicine
por: Wang, Yabin, et al.
Publicado: (2021)

Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
por: Ettcheto, Miren, et al.
Publicado: (2020)

Microglial Exosomes in Neurodegenerative Disease
por: Guo, Min, et al.
Publicado: (2021)

Current and Future Advancements of Raman Spectroscopy Techniques in Cancer Nanomedicine
por: Canetta, Elisabetta
Publicado: (2021)

Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects
por: Chopra, Hitesh, et al.
Publicado: (2022)

Nanomedicine-based commercial formulations: current developments and future prospects
por: Thapa, Raj Kumar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j0s2mbebmvc7qur9gotcfv1156